Duality Advisers’s Elevance Health ELV Stock Holding History

Duality Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,684	Closed	-$4.65M	–	619
2023 Q3	$4.65M	Buy	10,684 +1,082	+11%	+$491K	0.56%	20
2023 Q2	$4.27M	Buy	+9,602	New	+$4.43M	0.54%	27
2022 Q3	–	Sell	-9,758	Closed	-$4.71M	–	592
2022 Q2	$4.71M	Buy	+9,758	New	+$4.83M	0.46%	35
2022 Q1	–	Sell	-10,981	Closed	-$5.09M	–	684
2021 Q4	$5.09M	Buy	+10,981	New	+$4.62M	0.55%	32
2020 Q4	–	Sell	-5,390	Closed	-$1.45M	–	599
2020 Q3	$1.45M	Sell	5,390 -4,121	-43%	-$1.11M	0.09%	287
2020 Q2	$2.5M	Buy	+9,511	New	+$2.54M	0.23%	126
2019 Q4	–	Sell	-91,130	Closed	-$21.9M	–	396
2019 Q3	$21.9M	Buy	91,130 +82,340	+937%	+$22.6M	1.22%	10
2019 Q2	$2.48M	Sell	8,790 -11,970	-58%	-$3.27M	0.22%	132
2019 Q1	$5.96M	Buy	+20,760	New	+$6M	0.35%	79

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Duality Advisers's ELV Position: Q4 2023 in Review

Duality Advisers sold out of Elevance Health (ELV) in Q4 2023, closing a stake of 10,684 shares — an estimated $4.65M sold.

Duality Advisers first reported a position in ELV in Q1 2019 and held it in 9 quarters. The position peaked at $21.9M in Q3 2019. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Duality Advisers reported no remaining Elevance Health position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 10,684 Elevance Health shares in Q4 2023, an estimated $4.65M.
Duality Advisers first reported a position in Elevance Health in Q1 2019 and held it in 9 quarters.
Duality Advisers's Elevance Health position peaked at $21.9M in Q3 2019.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.